HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasuo Morishima Selected Research

HLA-A Antigens (HLA-A)

1/2020Impact of HLA Allele Mismatch at HLA-A, -B, -C, and -DRB1 in Single Cord Blood Transplantation.
1/2020Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor Transplantation.
3/2016Influence of Differently Licensed KIR2DL1-Positive Natural Killer Cells in Transplant Recipients with Acute Leukemia: A Japanese National Registry Study.
1/2016Gene Map of the HLA Region, Graves' Disease and Hashimoto Thyroiditis, and Hematopoietic Stem Cell Transplantation.
2/2015Biological significance of HLA locus matching in unrelated donor bone marrow transplantation.
2/2015Impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: a retrospective analysis from the Japan Society for Hematopoietic Cell Transplantation.
5/2013Different effects of HLA disparity on transplant outcomes after single-unit cord blood transplantation between pediatric and adult patients with leukemia.
3/2012Related transplantation with HLA-1 Ag mismatch in the GVH direction and HLA-8/8 allele-matched unrelated transplantation: a nationwide retrospective study.
6/2010Impact of highly conserved HLA haplotype on acute graft-versus-host disease.
1/2009Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasuo Morishima Research Topics

Disease

39Graft vs Host Disease (Graft-Versus-Host Disease)
06/2021 - 04/2002
28Leukemia
11/2021 - 06/2002
22Neoplasms (Cancer)
11/2018 - 12/2002
20Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020 - 02/2003
18Lymphoma (Lymphomas)
01/2018 - 12/2002
17Hematologic Neoplasms (Hematological Malignancy)
01/2021 - 08/2006
12Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 12/2005
11Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2011 - 12/2002
8Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2020 - 03/2012
8BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2018 - 10/2004
7B-Cell Lymphoma (Lymphoma, B Cell)
11/2018 - 10/2004
7Philadelphia Chromosome
11/2014 - 01/2004
6Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2020 - 07/2008
6Infections
07/2017 - 04/2002
5Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
11/2018 - 11/2007
5Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
12/2013 - 01/2007
4Hodgkin Disease (Hodgkin's Disease)
02/2015 - 03/2006
4Disease Progression
07/2013 - 03/2004
3Bronchiolitis Obliterans Syndrome
06/2013 - 04/2007
3Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
04/2010 - 10/2005
2COVID-19
10/2022 - 01/2021
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
09/2018 - 01/2010
2Pathologic Complete Response
02/2016 - 08/2012
2Multiple Myeloma
01/2016 - 01/2008
2Autoimmune Diseases (Autoimmune Disease)
01/2016 - 01/2011
2Aplastic Anemia (Anemia, Hypoplastic)
09/2011 - 12/2009
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
04/2010 - 06/2003
2Anorexia
01/2010 - 02/2009
2Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
01/2010 - 09/2009
2Diarrhea
12/2009 - 10/2004
2Carcinogenesis
09/2009 - 12/2005
2Epstein-Barr Virus Infections
08/2008 - 03/2006
2Lung Neoplasms (Lung Cancer)
10/2006 - 06/2004
2Mycosis Fungoides
10/2004 - 06/2003
1Myeloid Leukemia (Leukemia, Myelocytic)
01/2018
1Rheumatoid Arthritis
01/2018
1Inflammation (Inflammations)
01/2017
1Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
02/2016
1Communicable Diseases (Infectious Diseases)
01/2016

Drug/Important Bio-Agent (IBA)

14Rituximab (Mabthera)FDA Link
11/2018 - 04/2006
13HLA-A Antigens (HLA-A)IBA
01/2020 - 06/2002
10HLA Antigens (Human Leukocyte Antigens)IBA
01/2021 - 06/2002
8AntigensIBA
01/2019 - 04/2005
6HLA-DPB1 antigen (HLA DPB1)IBA
11/2021 - 03/2007
6HLA-B Antigens (HLA-B)IBA
01/2020 - 06/2002
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2018 - 01/2008
6Minor Histocompatibility AntigensIBA
05/2009 - 12/2002
5HLA-C Antigens (HLA-C)IBA
10/2017 - 06/2002
5Proteins (Proteins, Gene)FDA Link
05/2014 - 10/2004
4Methotrexate (Mexate)FDA LinkGeneric
01/2020 - 01/2009
4Doxorubicin (Adriamycin)FDA LinkGeneric
11/2018 - 12/2010
4Imatinib Mesylate (Gleevec)FDA Link
04/2014 - 10/2004
4Peptides (Polypeptides)IBA
08/2008 - 03/2004
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2018 - 02/2003
3Vincristine (Oncovin)FDA LinkGeneric
11/2018 - 12/2010
3Tacrolimus (Prograf)FDA LinkGeneric
03/2016 - 01/2009
3DNA (Deoxyribonucleic Acid)IBA
01/2016 - 04/2005
3Etoposide (VP 16)FDA LinkGeneric
03/2015 - 01/2008
3LigandsIBA
01/2008 - 08/2006
2Mycophenolic Acid (Cellcept)FDA LinkGeneric
01/2020 - 09/2014
2Prednisone (Sone)FDA LinkGeneric
11/2018 - 10/2011
2Cytarabine (Cytosar-U)FDA LinkGeneric
09/2018 - 01/2008
2NucleotidesIBA
01/2018 - 02/2013
2HLA-DRB1 Chains (HLA DRB1)IBA
01/2018 - 05/2013
2KIR ReceptorsIBA
01/2018 - 03/2007
2Toll-Like Receptor 1IBA
07/2017 - 01/2016
2Chemokine ReceptorsIBA
01/2017 - 04/2010
2Cyclosporine (Ciclosporin)FDA LinkGeneric
03/2016 - 12/2009
2ThrombomodulinIBA
10/2015 - 10/2015
2Granzymes (Granzyme)IBA
01/2011 - 10/2005
2Complement System Proteins (Complement)IBA
01/2010 - 02/2007
2CladribineFDA LinkGeneric
07/2009 - 10/2004
2EpitopesIBA
08/2008 - 08/2006
2EBV-encoded nuclear antigen 1IBA
08/2008 - 03/2007
2Messenger RNA (mRNA)IBA
03/2007 - 12/2005
2Interferon-gamma (Interferon, gamma)IBA
03/2007 - 06/2004
1Histone MethyltransferasesIBA
06/2021
1Amino AcidsFDA Link
01/2020
1Calcineurin InhibitorsIBA
01/2020
1HLA-DP Antigens (HLA-DP)IBA
01/2020
1Dihydrotachysterol (AT 10)IBA
11/2018
1Toll-Like Receptor 2IBA
07/2017
1Toll-Like Receptor 4IBA
07/2017
1Busulfan (Busulfex)FDA Link
12/2016
1lipoarabinomannan (LAM)IBA
02/2016

Therapy/Procedure

33Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2021 - 12/2002
32Transplantation
10/2022 - 01/2004
32Hematopoietic Stem Cell Transplantation
01/2021 - 04/2002
21Cell Transplantation
02/2020 - 02/2006
16Drug Therapy (Chemotherapy)
10/2020 - 12/2002
14Stem Cell Transplantation
12/2020 - 04/2005
14Therapeutics
12/2020 - 02/2003
7Immunotherapy
08/2008 - 06/2004
5Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
10/2022 - 02/2006
4Homologous Transplantation
01/2020 - 08/2007
2Induction Chemotherapy
10/2020 - 12/2009
1Blood Component Removal (Apheresis)
10/2022
1Autologous Transplantation
10/2020
1Aftercare (After-Treatment)
11/2018
1Donor Selection
04/2016